In addition to the increased portal pressure, formation of portosystemic collateral vessels in portal hypertension is influenced by a VEGF-dependent angiogenic process and can be markedly attenuated by interfering with the VEGF/VEGF receptor-2 signaling pathway. Here, VEGFA is linked to liver disorder.